Insulin Access News Today

Cost is a huge barrier to insulin access in LMICs. Human insulins are still out of the reach of many people with diabetes. When available, analogues are very expensive and can cost two to six times more than human insulins. There are also wide variations in price across countries

If Democrats have their way, new regulations will make it harder for Americans to access life-saving pharmaceuticals such as insulin.

A bipartisan bill was introduced to the Senate to reduce the soaring price of insulin for patients on both Medicare and private insurance plans.

Kaitlyn Wright and her mother, of Marks, Mississippi, had to look outside the Delta for help in treating Kaitlyns diabetes. Heres why.

Accessing Insulin in Developing Countries NEW YORK, New York — The World Health Organization reports that, in 2014, diabetes affected an estimated 422 million people worldwide. In 2016, diabetes accounted for around 1.6 million annual global deaths. When left untreated, diabetes can lead to long-term health problems. Additionally, the chances of premature death are higher without treatment. Developing countries often face these outcomes as they often experience struggles accessing insulin. D...

Policymakers are urged to include government negotiation to reduce insulin prices The Endocrine Society is calling on policymakers to include government negotiation as part of an overall strategy to reduce insulin prices in its updated position statement published today in The Journal of Clinical Endocrinology & Metabolism. More than 34 million Americans have diabetes, and another 88 million are at risk for developing the disease. The cost of insulin has nearly tripled in the past 15 years, an...